163 related articles for article (PubMed ID: 29662570)
1. Inter-Observer Agreement of Whole-Body Computed Tomography in Staging and Response Assessment in Lymphoma: The Lugano Classification.
Razek AAKA; Shamaa S; Lattif MA; Yousef HH
Pol J Radiol; 2017; 82():441-447. PubMed ID: 29662570
[TBL] [Abstract][Full Text] [Related]
2. Computed Tomography Assessment of Hepatic Metastases of Breast Cancer with Revised Response Evaluation Criteria in Solid Tumors (RECIST) Criteria (Version 1.1): Inter-Observer Agreement.
Ghobrial FEI; Eldin MS; Razek AAKA; Atwan NI; Shamaa SSA
Pol J Radiol; 2017; 82():593-597. PubMed ID: 29657622
[TBL] [Abstract][Full Text] [Related]
3. Whole-body diffusion-weighted imaging with background body signal suppression and quantitative apparent diffusion coefficient in the detection, staging, and grading of non-Hodgkin lymphoma.
Razek AAKA; Tawfik AM; Rahman MA; Teima S; Batouty NM
Pol J Radiol; 2023; 88():e177-e186. PubMed ID: 37057202
[TBL] [Abstract][Full Text] [Related]
4. Inter-observer variability influences the Lugano classification when restaging lymphoma.
Möller J; Steyn T; Combrinck N; Joubert G; Sherriff A; van Rensburg JJ
SA J Radiol; 2018; 22(1):1357. PubMed ID: 31754505
[TBL] [Abstract][Full Text] [Related]
5. Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.
Spijkers S; Littooij AS; Kwee TC; Tolboom N; Beishuizen A; Bruin MCA; Elias SG; van de Brug T; Enríquez G; Sábado C; Miller E; Granata C; de Lange C; Verzegnassi F; Greer MC; de Keizer B; Nievelstein RAJ
Eur Radiol; 2021 Mar; 31(3):1494-1504. PubMed ID: 32880696
[TBL] [Abstract][Full Text] [Related]
6. A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma.
Makita S; Maruyama D; Maeshima AM; Taniguchi H; Yuda S; Toyoda K; Yamauchi N; Fukuhara S; Munakata W; Kobayashi Y; Kurihara H; Izutsu K; Tobinai K
Asia Pac J Clin Oncol; 2020 Jun; 16(3):108-114. PubMed ID: 31802636
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Cheson BD; Fisher RI; Barrington SF; Cavalli F; Schwartz LH; Zucca E; Lister TA; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
J Clin Oncol; 2014 Sep; 32(27):3059-68. PubMed ID: 25113753
[TBL] [Abstract][Full Text] [Related]
8. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
Albano D; Patti C; Lagalla R; Midiri M; Galia M
J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
[TBL] [Abstract][Full Text] [Related]
9. [Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)].
Sýkorová A; Pytlík R; Móciková H; Belada D; Benešová K; Papajík T; Janíková A; Šálek D; Procházka V; Vokurka S; Campr V; Klener P; Kubáčková K; Trněný M
Klin Onkol; 2016; 29(4):295-302. PubMed ID: 27534788
[TBL] [Abstract][Full Text] [Related]
10. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
[TBL] [Abstract][Full Text] [Related]
11. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical).
Ricard F; Barrington S; Korn R; Brueggenwerth G; Trotman J; Cheson B; Salles G; Schwartz L; Goldmacher G; Jarecha R; Narang J; Broussais F; Galette P; Liu M; Bajpai S; Perlman E; Gillis J; Smalberg I; Terve P; Zahlmann G; Schmid A
J Nucl Med; 2023 Feb; 64(2):239-243. PubMed ID: 35835581
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma.
Martini K; Meier A; Opitz I; Weder W; Veit-Haibach P; Stahel RA; Frauenfelder T
Lung Cancer; 2016 Apr; 94():40-5. PubMed ID: 26973205
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
Trotman J; Barrington SF; Belada D; Meignan M; MacEwan R; Owen C; Ptáčník V; Rosta A; Fingerle-Rowson GR; Zhu J; Nielsen T; Sahin D; Hiddemann W; Marcus RE; Davies A;
Lancet Oncol; 2018 Nov; 19(11):1530-1542. PubMed ID: 30309758
[TBL] [Abstract][Full Text] [Related]
14. Staging and response assessment in lymphomas: the new Lugano classification.
Cheson BD
Chin Clin Oncol; 2015 Mar; 4(1):5. PubMed ID: 25841712
[TBL] [Abstract][Full Text] [Related]
15. RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 Patients.
Berzaczy D; Haug A; Staber PB; Raderer M; Kiesewetter B; Jaeger U; Kornauth C; Simonitsch-Klupp I; Mayerhoefer ME
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861433
[TBL] [Abstract][Full Text] [Related]
16. Inter-observer agreement of the Coronary Artery Disease Reporting and Data System (CAD-RADS
Abdel Razek AAK; Elrakhawy MM; Yossof MM; Nageb HM
Pol J Radiol; 2018; 83():e151-e159. PubMed ID: 30038693
[TBL] [Abstract][Full Text] [Related]
17. Whole-body MRI versus an [
Spijkers S; Littooij AS; Kwee TC; Tolboom N; Beishuizen A; Bruin MCA; Enríquez G; Sábado C; Miller E; Granata C; de Lange C; Verzegnassi F; de Keizer B; Nievelstein RAJ
Eur Radiol; 2021 Dec; 31(12):8925-8936. PubMed ID: 34021390
[TBL] [Abstract][Full Text] [Related]
18. Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.
Pricolo P; Ancona E; Summers P; Abreu-Gomez J; Alessi S; Jereczek-Fossa BA; De Cobelli O; Nolè F; Renne G; Bellomi M; Padhani AR; Petralia G
Cancer Imaging; 2020 Oct; 20(1):77. PubMed ID: 33109268
[TBL] [Abstract][Full Text] [Related]
19. Revised staging system for malignant lymphoma based on the Lugano classification.
Munakata W; Terauchi T; Maruyama D; Nagai H
Jpn J Clin Oncol; 2019 Oct; 49(10):895-900. PubMed ID: 31504700
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
Juweid ME; Mueller M; Alhouri A; A-Risheq MZ; Mottaghy FM
Cancer; 2021 Oct; 127(20):3727-3741. PubMed ID: 34286864
[No Abstract] [Full Text] [Related]
[Next] [New Search]